{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02286219: Phase 1 Interventional Completed Solid Tumors That Overexpress HER2 (HER2 Positive)
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03301090: Phase 1 Interventional Completed Corona Virus Infection
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00720135: Phase 1 Interventional Completed Anaplastic Large Cell Lymphoma
(2008)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04672434: Phase 1 Interventional Active, not recruiting Metastatic Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03214666: Phase 1/Phase 2 Interventional Terminated High-risk Myelodysplastic Syndromes
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03451162: Phase 1 Interventional Completed Breast Cancer
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03758716: Phase 2 Interventional Completed Atopic Dermatitis
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01544348: Phase 1 Interventional Completed Allergic Asthma
(2012)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03316794: Phase 1 Interventional Terminated Breast Cancer
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03682796: Phase 1 Interventional Completed Lymphoma
(2018)
Source URL:
Class:
CONCEPT